Italy vs Niger: Previously treated cases tested for RR-/MDR-TB
Italy
36.0%
in 2024
Niger
33.0%
in 2024
Italy rank
156th
Niger rank
158th
Previously treated cases tested for RR-/MDR-TB over time
- Italy
- Niger
How they compare
Italy currently reports 36.0% against 33.0% in Niger, a difference of 3.0%.
That makes Italy's figure about 1.1 times Niger's.
The two have swapped places 4 times across 15 shared years of data; in 2009 it was Italy ahead.
Italy ranks 156th and Niger ranks 158th of 180 countries.
Across the 3 decades both report, Italy averaged higher in 2 and Niger in 1.
Head to head by decade
| Decade | Italy | Niger | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 4.8% | 95.2% | Italy |
| 2010s | 75.7% | 47.5% | 28.1% | Italy |
| 2020s | 23.8% | 76.6% | 52.8% | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Italy or Niger?
- Italy, at 36.0% against 33.0% in Niger as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Italy and Niger?
- 3.0%, with Italy ahead.
- How many years of comparable data are there for Italy and Niger?
- 15 years are reported by both, from 2009 to 2024.
- How do Italy and Niger rank globally for previously treated cases tested for rr-/mdr-tb?
- Italy ranks 156th and Niger ranks 158th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.